Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Merchants Bancorp B | MBINO | Nov 15, 2024 | 25.36 | +0.07 |
Merchants Bancorp C Pref | MBINN | Nov 15, 2024 | 22.69 | -0.04 |
Merchants Bancorp Pref D | MBINM | Nov 15, 2024 | 26.42 | -0.90 |
Merck & Co | MRK | Nov 15, 2024 | 96.31 | -2.08 |
Mercurity Fintech | MFH | Nov 15, 2024 | 3.78 | +5.88 |
Mercury General | MCY | Nov 15, 2024 | 73.00 | -0.55 |
Mercury Systems | MRCY | Nov 15, 2024 | 39.32 | -3.72 |
Mereo BioPharma ADR | MREO | Nov 15, 2024 | 3.53 | -7.59 |
Meridian | MRBK | Nov 15, 2024 | 14.23 | +0.57 |
MeridianLink | MLNK | Nov 15, 2024 | 22.02 | -3.00 |
Merit Medical Systems | MMSI | Nov 15, 2024 | 101.83 | +0.62 |
Meritage Homes | MTH | Nov 15, 2024 | 179.41 | -1.00 |
Merrill Lynch & Co. | IPB | Nov 15, 2024 | 26.20 | +0.38 |
Mersana Therapeutics | MRSN | Nov 15, 2024 | 2.21 | -12.30 |
Merus N.V | MRUS | Nov 15, 2024 | 46.58 | -6.20 |
Mesa Air Group | MESA | Nov 15, 2024 | 0.86 | -2.42 |
Mesa Laboratories | MLAB | Nov 15, 2024 | 102.44 | -2.07 |
Mesa Royalty Trust | MTR | Nov 15, 2024 | 6.25 | +6.47 |
Mesabi Royalty Trust | MSB | Nov 15, 2024 | 25.51 | -1.16 |
Mesoblast ADR | MESO | Nov 15, 2024 | 10.04 | -11.31 |
Meta Materials | MMAT | Nov 15, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Nov 15, 2024 | 554.08 | -4.00 |
Metagenomi | MGX | Nov 15, 2024 | 1.82 | -3.19 |
Metal Sky Star Acquisition | MSSA | Nov 15, 2024 | 12.00 | 0.00 |
Metalla Royalty & Streaming | MTA | Nov 15, 2024 | 2.85 | -7.17 |
Metallus | MTUS | Nov 15, 2024 | 14.49 | -2.03 |
Metals Acquisition | MTAL | Nov 15, 2024 | 11.65 | -3.40 |
Methalpa Technology Holding | MATH | Nov 15, 2024 | 1.00 | -11.16 |
Methanex | MEOH | Nov 15, 2024 | 42.64 | -0.49 |
Methode Electronics | MEI | Nov 15, 2024 | 9.30 | -4.32 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.